1180 related articles for article (PubMed ID: 25512156)
21. Benefits, harms and cost-effectiveness of cervical screening, triage and treatment strategies for women in the general population.
Simms KT; Keane A; Nguyen DTN; Caruana M; Hall MT; Lui G; Gauvreau C; Demke O; Arbyn M; Basu P; Wentzensen N; Lauby-Secretan B; Ilbawi A; Hutubessy R; Almonte M; De Sanjosé S; Kelly H; Dalal S; Eckert LO; Santesso N; Broutet N; Canfell K
Nat Med; 2023 Dec; 29(12):3050-3058. PubMed ID: 38087115
[TBL] [Abstract][Full Text] [Related]
22. Health impact of delayed implementation of cervical cancer screening programs in India: A modeling analysis.
Campos NG; Tsu V; Jeronimo J; Regan C; Resch S; Clark A; Sy S; Kim JJ
Int J Cancer; 2019 Feb; 144(4):687-696. PubMed ID: 30132850
[TBL] [Abstract][Full Text] [Related]
23. Resources Required for Cervical Cancer Prevention in Low- and Middle-Income Countries.
Campos NG; Sharma M; Clark A; Kim JJ; Resch SC
PLoS One; 2016; 11(10):e0164000. PubMed ID: 27711124
[TBL] [Abstract][Full Text] [Related]
24. Optimal human papillomavirus vaccination strategies to prevent cervical cancer in low-income and middle-income countries in the context of limited resources: a mathematical modelling analysis.
Drolet M; Laprise JF; Martin D; Jit M; Bénard É; Gingras G; Boily MC; Alary M; Baussano I; Hutubessy R; Brisson M
Lancet Infect Dis; 2021 Nov; 21(11):1598-1610. PubMed ID: 34245682
[TBL] [Abstract][Full Text] [Related]
25. Comparative assessment of test characteristics of cervical cancer screening methods for implementation in low-resource settings.
Asgary R; Beideck E; Naderi R
Prev Med; 2022 Jan; 154():106883. PubMed ID: 34785209
[TBL] [Abstract][Full Text] [Related]
26. Age at last screening and remaining lifetime risk of cervical cancer in older, unvaccinated, HPV-negative women: a modelling study.
Malagón T; Kulasingam S; Mayrand MH; Ogilvie G; Smith L; Bouchard C; Gotlieb W; Franco EL
Lancet Oncol; 2018 Dec; 19(12):1569-1578. PubMed ID: 30392810
[TBL] [Abstract][Full Text] [Related]
27. Human Papilloma Virus self-sampling performance in low- and middle-income countries.
Kamath Mulki A; Withers M
BMC Womens Health; 2021 Jan; 21(1):12. PubMed ID: 33407355
[TBL] [Abstract][Full Text] [Related]
28. Towards the elimination of cervical cancer in low-income and lower-middle-income countries: modelled evaluation of the effectiveness and cost-effectiveness of point-of-care HPV self-collected screening and treatment in Papua New Guinea.
Nguyen DTN; Simms KT; Keane A; Mola G; Bolnga JW; Kuk J; Toliman PJ; Badman SG; Saville M; Kaldor J; Vallely A; Canfell K
BMJ Glob Health; 2022 Mar; 7(3):. PubMed ID: 35241461
[TBL] [Abstract][Full Text] [Related]
29. Optimal Cervical Cancer Screening in Women Vaccinated Against Human Papillomavirus.
Kim JJ; Burger EA; Sy S; Campos NG
J Natl Cancer Inst; 2017 Feb; 109(2):. PubMed ID: 27754955
[TBL] [Abstract][Full Text] [Related]
30. Cervical cancer screening program based on primary DNA-HPV testing in a Brazilian city: a cost-effectiveness study protocol.
Teixeira JC; Vale DB; Bragança JF; Campos CS; Discacciati MG; Zeferino LC
BMC Public Health; 2020 Apr; 20(1):576. PubMed ID: 32345284
[TBL] [Abstract][Full Text] [Related]
31. Human papillomavirus screening and cervical cancer prevention.
Sasieni PD
J Am Med Womens Assoc (1972); 2000; 55(4):216-9. PubMed ID: 10935355
[TBL] [Abstract][Full Text] [Related]
32. Interventions to close the divide for women with breast and cervical cancer between low-income and middle-income countries and high-income countries.
Denny L; de Sanjose S; Mutebi M; Anderson BO; Kim J; Jeronimo J; Herrero R; Yeates K; Ginsburg O; Sankaranarayanan R
Lancet; 2017 Feb; 389(10071):861-870. PubMed ID: 27814963
[TBL] [Abstract][Full Text] [Related]
33. Detection of human papillomavirus in fresh and dried urine through an automated system for cervical cancer screening in low- and middle-income countries.
Tanzi E; Bianchi S; Fappani C; Gori M; Colzani D; Passera I; Tincati C; Canuti M; Raviglione M; Amendola A
J Med Virol; 2023 May; 95(5):e28802. PubMed ID: 37219045
[TBL] [Abstract][Full Text] [Related]
34. Detection of human papillomavirus DNA in routine cervical scraping samples: use for a national cervical cancer screening program in a developing nation.
Othman N; Othman NH
Asian Pac J Cancer Prev; 2014; 15(5):2245-9. PubMed ID: 24716964
[TBL] [Abstract][Full Text] [Related]
35. Treatment approaches for women with positive cervical screening results in low-and middle-income countries.
Wentzensen N; Chirenje ZM; Prendiville W
Prev Med; 2021 Mar; 144():106439. PubMed ID: 33678236
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of the effectiveness of high-risk human papilloma self-sampling test for cervical cancer screening in Bolivia.
Allende G; Surriabre P; Ovando N; Calle P; Torrico A; Villarroel J; Bossens M; Fontaine V; Rodriguez P
BMC Infect Dis; 2020 Apr; 20(1):259. PubMed ID: 32245369
[TBL] [Abstract][Full Text] [Related]
37. Predictors of Cervical Cancer Screening Among Infrequently Screened Women Completing Human Papillomavirus Self-Collection: My Body My Test-1.
Lea CS; Perez-Heydrich C; Des Marais AC; Richman AR; Barclay L; Brewer NT; Smith JS
J Womens Health (Larchmt); 2019 Aug; 28(8):1094-1104. PubMed ID: 30874477
[No Abstract] [Full Text] [Related]
38. Cancer Screening in Low- and Middle-Income Countries.
Martinez ME; Schmeler KM; Lajous M; Newman LA
Am Soc Clin Oncol Educ Book; 2024 Jun; 44(3):e431272. PubMed ID: 38843475
[TBL] [Abstract][Full Text] [Related]
39. Trials and projects on cervical cancer and human papillomavirus prevention in sub-Saharan Africa.
Adefuye PO; Broutet NJ; de Sanjosé S; Denny LA
Vaccine; 2013 Dec; 31 Suppl 5():F53-9. PubMed ID: 24331748
[TBL] [Abstract][Full Text] [Related]
40. Cancer Screening.
Am Fam Physician; 2016 Apr; 93(8):Online. PubMed ID: 27175849
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
